Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/1690
Full metadata record
DC FieldValueLanguage
dc.contributor.authorParker Jen_US
dc.contributor.authorOaten Aen_US
dc.contributor.authorGeorge Ven_US
dc.date.accessioned2022-05-19T23:22:29Z-
dc.date.available2022-05-19T23:22:29Z-
dc.date.issued2022-
dc.identifier.urihttp://dora.health.qld.gov.au/qldresearchjspui/handle/1/1690-
dc.descriptionCairns & Hinterland Hospital and Health Service (CHHHS) affiliated authors: J Parker, A Oatenen_US
dc.description.abstractIntroduction/Aim: Malignant pleural effusion (MPE) is associated with poor survival, disabling dyspnoea, and psychological distress. Thoracocentesis provides diagnostic yields of 40%–60%, however with the expansion of personalized oncological treatments further material is increasingly needed to determine therapeutic options. Patients often experience multiple procedures, ongoing breathlessness and diagnostic delay. This retrospective analysis aims to quantify the number of pleural procedures that patients with MPE undergo at a regional Australian centre and the associated healthcare burden that they experience. Methods: A retrospective review of all pleural procedures performed at Cairns Hospital between June 2019 and June 2020 was performed. Patients diagnosed with MPE were reviewed to determine demographics, presentation, number of procedures and time taken to deliver actionable histocytology and definitive pleural management. Results: Excluding operative and trauma drains, 121 patients underwent pleural intervention over the 12-month period. Thirty-one (25.6%) of these individuals were diagnosed with MPE. Median age was 69.3 years, with median survival of 128 days. Eighty percent were referred acutely from emergency or other inpatient teams, with a median of 1 day until initial pleural intervention. Sixteen (51.6%) of those with MPE had positive initial cytology. However, initial pleural fluid cytology was adequate to guide management in only 10 (34.4%) of diagnostic procedures. Patients underwent a median of two diagnostic procedures before actionable histocytology was delivered, with 19 (61.3%) undergoing more than one pleural procedure. Twenty-one (68%) patients underwent talc pleurodesis. Of these individuals 14 (66.7%) had freedom from re-intervention at 3 months, and 11 (52.3%) at 6 months. Median MPE related LOS was 12 days total. Conclusion: This is, to our knowledge, the first assessment of pleural procedure burden at a regional Australian centre. The majority of patients with MPE required multiple pleural procedures and spent a considerable portion of their remaining life-expectancy in hospital. Current pathways are prolonged and are likely to lead to ongoing dyspnoea and uncertainty. New strategies to manage these patients need to be evaluated.en_US
dc.description.sponsorshipGrant Support: Dr George reports a PhD scholarship from the Australian Government Research Training Program (RTP).en_US
dc.language.isoenen_US
dc.relation.ispartofRespirologyen_US
dc.titleRetrospective analysis of procedural burden and diagnostic delay in patients with malignant pleural effusionen_US
dc.typeArticleen_US
dc.relation.conferenceTSANZSRS 2022 The Australia & New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand (ANZSRS/TSANZ), Annual Scientific Meeting for Leaders in Lung Health & Respiratory Science, 31 Mar – 2 Apr 2022en_US
dc.identifier.doiRetrospective analysis of procedural burden and diagnostic delay in patients with malignant pleural effusion-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.languageiso639-1en-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.fulltextNo Fulltext-
item.grantfulltextnone-
Appears in Sites:Cairns & Hinterland HHS Publications
Show simple item record

Page view(s)

82
checked on Dec 31, 2024

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.